“Probable Reversible Encephalopathy With Ceftazidime Avibactam and Aztreonam: A Case Report”. 2026. Asian Journal of Pharmaceutical and Health Sciences 16 (2): 3283-87. https://doi.org/10.5530/ajphs.2026.16.94.